Universal regimens or universal access to drug susceptibility testing for tuberculosis?

R Acquah, J Furin - Lancet Infectious Diseases, 2019 - scienceportal.msf.org
A universal regimen. At times this appears to be the Holy Grail in tuberculosis treatment. For
decades, policy makers, public health specialists, and donors have argued that in order to …

Unrecognised Ebola virus infection in contact persons: what can we learn from it?

TE Fletcher, H Bower - The Lancet Infectious Diseases, 2019 - thelancet.com
The epidemic of Ebola virus disease in west Africa in 2014–16 was the largest and most
complex the world has ever seen. The four pillars of Ebola response include: case …